Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced

J Turkson1, T Bowman, J Adnane

  • 1Molecular Oncology, Moffitt Cancer Center, University of South Florida College of Medicine, Tampa, Florida 33612, USA.

Insights

Abnormal Signal Transducers and Activators of Transcription (STATs) activation, particularly Stat3, drives oncogenesis. Src oncoprotein signaling requires both tyrosine and serine phosphorylation of Stat3, mediated by p38 and JNK kinases, for cell transformation.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Oncogenesis

Background:

  • Signal transducers and activators of transcription (STATs) regulate normal cellular processes.
  • Aberrant STAT activation, specifically Stat3, is linked to cancer development.
  • The Src oncoprotein activates Stat3, promoting gene expression and cell transformation.

Purpose of the Study:

  • To investigate the signaling pathways responsible for constitutive Stat3 activation in Src-driven oncogenesis.
  • To elucidate the roles of specific kinases in Stat3 phosphorylation and transcriptional activity.

Main Methods:

  • Utilized dominant-negative Ras and Rac1 proteins to block Stat3-mediated gene regulation.
  • Assessed the impact of p38 and c-Jun N-terminal kinase (JNK) inhibition on Stat3 phosphorylation and activity.
  • Performed in vitro kinase assays using purified Stat3 and JNK/p38 kinases.
  • Examined the effect of p38 inhibition on Src-induced cell transformation.

Main Results:

  • Src-induced Stat3 activation and transformation depend on both tyrosine and serine phosphorylation.
  • Ras and Rac1 signaling activate p38 and JNK, which are required for Stat3 serine phosphorylation.
  • Inhibition of p38 and JNK suppressed Stat3 serine phosphorylation and Stat3-mediated gene regulation.
  • p38 kinase directly phosphorylates Stat3 on serine in vitro.
  • Inhibiting p38 suppressed v-Src transformation, but not v-Ras transformation.

Conclusions:

  • Ras/Rac1-mediated p38 and JNK signaling pathways are essential for Src oncoprotein-induced Stat3 transcriptional activity.
  • These findings reveal a signaling network converging on Stat3, involving both tyrosine and serine/threonine kinases, critical for oncogenesis.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...